Metis Global Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624K Sell
9,262
-1,781
-16% -$119K 0.01% 527
2026
Q1
$694K Sell
11,043
-1,420
-11% -$98.9K 0.02% 518
2025
Q4
$827K Sell
12,463
-703
-5% -$45.4K 0.02% 496
2025
Q3
$886K Sell
13,166
-5,208
-28% -$412K 0.02% 500
2025
Q2
$1.6M Sell
18,374
-5,746
-24% -$450K 0.04% 359
2025
Q1
$1.65M Buy
24,120
+1,926
+9% +$157K 0.05% 349
2024
Q4
$1.73M Buy
22,194
+1,028
+5% +$76.1K 0.05% 319
2024
Q3
$1.42M Buy
21,166
+2,684
+15% +$220K 0.04% 369
2024
Q2
$2.1M Buy
18,482
+317
+2% +$40.1K 0.07% 231
2024
Q1
$2.52M Buy
18,165
+221
+1% +$27.8K 0.09% 199
2023
Q4
$2.23M Sell
17,944
-1,384
-7% -$141K 0.09% 206
2023
Q3
$1.8M Buy
19,328
+2,526
+15% +$285K 0.09% 239
2023
Q2
$2.16M Buy
16,802
+146
+0.9% +$17.7K 0.12% 184
2023
Q1
$1.94M Buy
16,656
+3,576
+27% +$400K 0.12% 170
2022
Q4
$1.48M Buy
13,080
+5,666
+76% +$622K 0.13% 179
2022
Q3
$597K Buy
7,414
+391
+6% +$33.1K 0.1% 240
2022
Q2
$524K Buy
7,023
+891
+15% +$81.3K 0.08% 276
2022
Q1
$784K Buy
6,132
+2,752
+81% +$301K 0.09% 193
2021
Q4
$453K Buy
+3,380
New +$486K 0.13% 179

Other funds holding DXCM

Metis Global Partners's DXCM Position: Q2 2026 in Review

Metis Global Partners reduced its DexCom (DXCM) stake by 16% in Q2 2026, selling an estimated $119K and leaving 9,262 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #527.

Metis Global Partners first reported a position in DXCM in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.52M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Metis Global Partners held 9,262 shares of DexCom worth $624K as of Q2 2026.
  • Metis Global Partners sold 1,781 DexCom shares in Q2 2026, an estimated $119K.
  • DexCom made up 0.01% of Metis Global Partners's portfolio in Q2 2026, its #527 holding.
  • Metis Global Partners first reported a position in DexCom in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's DexCom position peaked at $2.52M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.